Eric Lawitz - Articles and news items

Gilead logo

Gilead reports interim data from Phase 2 LONESTAR study

Industry news, News / 2 May 2013 / Gilead Sciences

Gilead Sciences announced plans to initiate a third Phase 3 clinical trial…

Gilead logo

Data from Phase 3 studies of Gilead’s sofosbuvir for hepatitis C to be presented at 48th Annual EASL Meeting

Industry news, News / 23 April 2013 / Gilead Sciences

Detailed results from four Phase 3 clinical trials…


The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...